Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
Transcription Factors
100%
Malignant Neoplasm
75%
Leukemia
50%
Metastasis
25%
Chemotherapy
25%
Protein Tyrosine Kinase Inhibitor
25%
Non-Epithelial Cancer
25%
Drug Resistance
25%
Fibrosis
25%
Monoclonal Antibody
25%
Medicine and Dentistry
Hematologic Malignancy
100%
Mesenchymal-Epithelial Transition
100%
Transcription Factors
50%
Metastatic Carcinoma
25%
Cancer Cell
25%
Leukemia
25%
Malignant Neoplasm
12%
Programmed Cell Death
12%
down Regulation
12%
Prognostic Factor
12%
Predictive Factor
12%
Upregulation
12%
Fibrosis
12%
Radiation Therapy
12%
Embryo Development
12%
Tyrosine-Kinase Inhibitor
12%
Lymphoma Cell
12%
Non-Epithelial Cancer
12%
Drug Resistance
12%
Monoclonal Antibody
12%
Biochemistry, Genetics and Molecular Biology
Mesenchymal-Epithelial Transition
100%
Transcription Factors
50%
Cancer Cell
25%
down Regulation
12%
Upregulation
12%
Tyrosine Kinase Inhibitor
12%
Embryogenesis
12%
Myeloid
12%
Drug Resistance
12%
Monoclonal Antibody
12%